The largest database of trusted experimental protocols

Variant studio v2

Manufactured by Illumina

Variant Studio v2.2 is a software application developed by Illumina for the analysis and visualization of genetic variants. It provides a comprehensive suite of tools for the identification, annotation, and interpretation of DNA sequence variations. The core function of Variant Studio v2.2 is to enable researchers and clinicians to efficiently process and analyze genomic data from various sequencing platforms.

Automatically generated - may contain errors

3 protocols using variant studio v2

1

Identifying Disease-Causing Gene Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
To identify a potential candidate gene, genomic DNA of one of the affected individuals (V-4) was used to perform whole exome sequencing. The sample was prepared using Agilent SureSelect Target Enrichment Kit by following the manufacturer’s guide. The libraries were sequenced with Illumina HiSeq 2000/2500 sequencer. The BWA Enrichment application of BaseSpace (Illumina Inc. 5200 Illumina Way|San Diego, CA, 92122, USA) was used to analyze the reads. Alignment was performed with Burrows-Wheeler Aligner (BWA) and the variants were called with Genome Analysis Toolkit (GATK). All the called variants were annotated with Illumina Variant Studio v2.2. Based upon the inheritance pattern observed in the pedigree of the present family, we filtered the biallelic variants. Exome sequence data was carefully analyzed and the presence of all suspected homozygous variants was checked in the public databases [dbSNP (https://www.ncbi.nlm.nih.gov/snp/ accessed on 10 February 2022), 1000 Genomes browser (https://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/ accessed on 10 February 2022), Exome Variant Server (https://evs.gs.washington.edu/EVS/ accessed on 10 February 2022), gnomAD (https://gnomad.broadinstitute.org/ accessed on 10 February 2022)], and the exome data of 53 healthy controls collected from different ethnic groups of Pakistan.
+ Open protocol
+ Expand
2

Exome Sequencing for Rare Disease Discovery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Library preparation, indexing and target enrichment for exome sequencing was carried out using the Nextera Rapid Capture Exome kit (Illumina), targeting 45 Mb of exonic coding sequence. Paired-end (2 × 87 cycle) single-plex sequencing was carried out on a MiSeq instrument (Illumina). Secondary data analysis, including alignment of reads against human reference genome hg19, was carried out using MiSeq Reporter v2.5.1 (Illumina) and variants were called and annotated using Illumina Variant Studio v2.2. Homozygous or compound heterozygous variants with allele frequency <1%, predicted to result in loss of protein function, were considered as potential causes of the MAM-negative phenotype. Selected alignments were further visualised using Integrative Genomics Viewer (IGV v2.3)28 (link),29 (link).
+ Open protocol
+ Expand
3

Variant Annotation and Reporting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Annotation of detected variants was performed using Illumina Variant Studio v2.2 software (Illumina). Every variant with an allele frequency < 10% was removed before review. Detected variants were marked with a PASS filter flag if the following criteria were met: the variant was present in each pool, the cumulative depth was 1000 × per pool, and the average depth was 500 × per pool. Variants were classified using the ClinVar (http://www.ncbi.nlm.nih.gov/clinvar) and COSMIC (http://cancer.sanger.ac.uk/cosmic) databases. Pathogenic and likely pathogenic variants were reported according to standard guidelines (http://www.ncbi.nlm.nih.gov/clinvar; http://cancer.sanger.ac.uk/cosmic).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!